From News&Views: Members of LRAC work to effectively advocate AMCP’s positions on a wide range of current and anticipated state and federal legislative and regulatory issues. AMCP News&Views caught up with committee chair Nisreen Shamseddine to get her perspective on the committee’s goals for this year.
From News&Views: Section 3002 of the 21st Century Cures Act, which was signed into law in December 2016, requires the FDA to develop one or more sets of new guidances regarding the collection of patient experience data.
AMCP CEO Blog: PA is a crucial but often-misunderstood utilization management tool in the pharmacy benefit space. The bad rap that PAs have received recently, I believe, comes from either misinformation about the process or glitches in specific systems that can easily be corrected.